治疗前放射学MRI变量与动态增强MRI对喉癌及下咽癌放疗结局的预后价值
回顾性纳入320例接受放疗的喉癌及下咽癌患者,评估治疗前解剖学MRI变量及DCE-MRI参数对局部控制、疾病控制和总生存的预后价值。多因素分析显示AUC60p95≥31.7 mmol·s/L预示更好OS(HR=0.25,P<.001),肿瘤体积大预示更差DC(HR=3.42,P<.001)和OS(HR=3.27,P<.001),校正混杂因素后解剖学MRI变量对任一结局均无显著预后价值。
要点
- 治疗前AUC60p95≥31.7 mmol·s/L预示更好OS(HR=0.25,P<.001)
- 肿瘤体积大预示更差DC(HR=3.42,P<.001)和OS(HR=3.27,P<.001)
- 校正混杂因素后解剖学MRI变量对LC、DC、OS均无显著预后价值
核心结论
- 治疗前低AUC60p95预示更差OS,提示肿瘤灌注差导致生存更差。
- 大肿瘤体积也预示更差DC和OS。
- 校正年龄、T分期、N分期和肿瘤体积等混杂因素后,解剖学MRI参数对任一评估的治疗结局均无预后价值。
研究设计与样本
- 回顾性纳入320例接受放疗的喉癌及下咽癌患者。
- 评估治疗前MRI的解剖学肿瘤特征:软骨侵犯、喉外扩散、前连合受累、声门上间隙受累及喉旁间隙受累。
- 89例患者有治疗前DCE-MRI,测定肿瘤体积内60秒对比剂分布曲线下面积的中位数和95百分位数(AUC60median和AUC60p95)。
主要发现
- 单因素log-rank检验确定喉外扩散、肿瘤体积和T分期预示更差LC、DC和OS。
- 低AUC60p95(<31.7 mmol·s/L)和甲状软骨侵犯预示更差OS。
- 多因素Cox比例风险模型显示AUC60p95≥31.7 mmol·s/L预示更好OS(HR=0.25,P<.001)。
- 肿瘤体积预示DC(HR=3.42,P<.001)和OS(HR=3.27,P<.001)。
- 校正混杂因素后,解剖学MRI变量对LC、DC或OS均无显著预后价值。
关键数值与推荐
- AUC60p95≥31.7 mmol·s/L预示更好OS(HR=0.25,P<.001)。
- 肿瘤体积预示DC(HR=3.42,P<.001)和OS(HR=3.27,P<.001)。
- 低AUC60p95(<31.7 mmol·s/L)和甲状软骨侵犯在单因素分析中预示更差OS。
- 喉外扩散、肿瘤体积和T分期在单因素分析中预示更差LC、DC和OS。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to determine the prognostic value of radiological magnetic resonance imaging (MRI) variables and dynamic contrast enhanced (DCE)-MRI for local control (LC), disease control (DC), and overall survival (OS) in laryngeal and hypopharyngeal cancer patients after radiotherapy. METHODS: 320 patients treated with radiotherapy were retrospectively included. Pretreatment MRIs were evaluated for the following anatomical tumor characteristics: cartilage invasion, extralaryngeal spread, and involvement of the anterior commissure, pre-epiglottic space, and paralaryngeal space.Pretreatment DCE-MRI was available in 89 patients. The median and 95th percentile of the 60-second area under the contrast-distribution-curve (AUC60median and AUC60p95) were determined in the tumor volume. RESULTS: Univariable log-rank test determined that extralaryngeal spread, tumor volume and T-stage were prognostic for worse LC, DC, and OS. A low AUC60p95 (<31.7 mmol·s/L) and thyroid cartilage invasion were prognostic for worse OS.In multivariable analysis, a Cox proportional hazard model showed that a AUC60p95 ≥ 31.7 mmol·s/L was prognostic for better OS (HR=0.25, P<.001). Tumor volume was prognostic for DC (HR=3.42, P<.001) and OS (HR=3.27, P<.001). No anatomical MRI variables were significantly prognostic for LC, DC, or OS in multivariable analysis when corrected for confounders. CONCLUSION: Low pretreatment AUC60p95 is prognostic for a worse OS, suggesting that poor tumor perfusion leads to worse survival. Large tumor volume is also prognostic for worse DC and OS. Anatomical MRI parameters are not prognostic for any of the evaluated treatment outcomes when corrected for confounders like age, T-stage, N-stage, and tumor volume.
引用
- Smits HJG, Vink SJ, de Ridder M, et al. Prognostic value of pretreatment radiological MRI variables and dynamic contrast-enhanced MRI on radiotherapy treatment outcome in laryngeal and hypopharyngeal tumors. Clin Transl Radiat Oncol. 2024. PMID: 39318679. doi:10.1016/j.ctro.2024.100857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。